½ÃÀ庸°í¼­
»óǰÄÚµå
1589749

¼¼°èÀÇ ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°, »ç¿ë¼º, Ç÷°ü À¯Çü, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Endoscopic Vessel Harvesting Market by Product (Accessories, Endoscopes, EVH Systems), Usability (Disposable, Reusable), Vessel Type, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 191 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀåÀº 2023³â 20¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 22¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.70%·Î ¼ºÀåÇØ 2030³â¿¡´Â 39¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ(EVH)Àº °ü»ó µ¿¸Æ ¿ìȸ À̽Ä(CABG)¿¡ ÇÊ¿äÇÑ Ç÷°ü(ÁÖ·Î º¹Àç Á¤¸Æ)À» º¸ÀåÇϱâ À§ÇØ ½ÉÀå ¼ö¼ú¿¡ »ç¿ëµÇ´Â ³·Àº ħ½À ¼ö¼úÀÔ´Ï´Ù. EVHÀÇ Çö´ëÀû ¹üÀ§´Â ¿Ü°úÀû ¿Ü»ó °æ°¨, »óó ÇÕº´Áõ °¨¼Ò, ȯÀÚ È¸º¹ ½Ã°£ Çâ»óÀÇ Á߿伺À» °­Á¶Çϸç, µû¶ó¼­ ¼¼°è ½ÉÀå Áúȯ Ä¡·á½Ç¿¡¼­ µµÀÔÀÌ ÇÊ¿äÇÕ´Ï´Ù. µÇ¾î ÀÖ½À´Ï´Ù. ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛÀÇ ÁÖ¿ä ¿ëµµ´Â ½ÉÀ庴 ȯÀÚÀÇ ¼ö¼ú ¼ºÀûÀÇ °³¼±À̸ç, ÁÖ·Î CABG ¼ö¼úÀ» À§ÇÑ º´¿ø°ú ½ÉÀå Àü¹®¼¾ÅͰ¡ ´ë»óÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ³»½Ã°æ ±â¼úÀÇ Áøº¸ µî Ç÷¯½ºÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ ºñ¿ë È¿°úÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ ÀýÂ÷¸¦ Áß½ÃÇÏ´Â °¡¿îµ¥, EVH ½ÃÀåÀº ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ Á¤ºñµÇ°í ÀÖ´Â ½ÅÈï±¹ ½ÃÀå¿¡¼­ ¼ºÀå ±âȸ¸¦ ã°í ÀÖ½À´Ï´Ù. ÀΰøÁö´É°ú ·Îº¿ °øÇÐÀÇ ÅëÇÕ°ú ÇÔ²² Àåºñ ¹× À̹ÌÁö ÇÁ·Î¼¼½ÌÀÇ Ã·´Ü ¹ßÀüÀº ±â¼ú Çõ½Å°ú ½ÃÀå ¸®´õ½ÊÀÇ ÀáÀçÀû ¿µ¿ªÀ» º¸¿© ÁÖ¸ç ºñÁî´Ï½º ¼ºÀå ±âȸ¿¡ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ½ÃÀåÀº EVH ÀåºñÀÇ °íºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¤ Áؼö, °í±Þ ³»½Ã°æ ±â¼úÀ» Ȱ¿ëÇÏ´Â ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ· µîÀÇ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÅÈï±¹ ½ÃÀå °³Ã´ÀÌ Áö¿¬µÈ Áö¿ª¿¡¼­´Â ÀÇ·á Á¦°ø¾÷üÀÇ ÀÎÁöµµ°¡ ³·¾Æ ½ÃÀå ħÅõ°¡ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ÇöÀçÀÇ ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ, ±â¾÷Àº EVH ±â¼úÀÇ »ç¿ëÀ» ÀÇ·á Á¾»çÀÚ¿¡°Ô ½ºÅ³ ¾÷ ½ÃŰ´Â Æ®·¹ÀÌ´× ÇÁ·Î±×·¥ÀÇ È®´ë¿¡ ÁÖ·ÂÇØ, ¸ðµç ÀÇ·á ȯ°æ¿¡¼­ ³Î¸® ä¿ëÇÒ ¼ö ÀÖ´Â ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» ¼³°èÇϱâ À§ÇÑ R&D¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù. EVH ½ÃÀåÀÇ ¼º°ÝÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ºü¸£°Ô ÁøÈ­Çϰí Àֱ⠶§¹®¿¡ ÀáÀçÀûÀÎ Àå¾Ö¸¦ ±Øº¹Çϸ鼭 Å« ½ÃÀå Á¡À¯À²À» ¾òÀ¸·Á¸é ±â¼ú Çõ½Å°ú Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÁßÁ¡À» µÑ Çʿ䰡 ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 20¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 22¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 39¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 9.70%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ½ÉÇ÷°ü Áúȯ ȯÀÚ Áõ°¡
    • Àúħ½ÀÀûÀΠäÃë ¹æ¹ý¿¡ÀÇ ±âÈ£ÀÇ °íÁ¶
    • ÀÇ·á ÀÎÇÁ¶ó ½Ã¼³À» ¾÷±×·¹À̵åÇϱâ À§ÇÑ Á¤ºÎ º¸Á¶±Ý°ú ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ´ëü Ä¡·á¹ýÀÇ ÀÌ¿ë °¡´É¼º
  • ½ÃÀå ±âȸ
    • ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½Ã½ºÅÛÀÇ Á¦Ç° °³¹ß°ú »õ·Î¿î Áøº¸
    • EVH ½Ã½ºÅÛÀÇ ÀÏȸ¿ë ºÎ¹®ÀÇ º¸±Þ
  • ½ÃÀåÀÇ °úÁ¦
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·

Porter's Five Forces : ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ¼³¸íÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ¼¼ºÐÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡µµ ´äº¯Çϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ ½ÉÇ÷°ü ÁúȯÀÇ Áõ·Ê°¡ Áõ°¡
      • Àúħ½À¼º äÃë¹ýÀÇ È£°¨µµ°¡ ³ô¾ÆÁö°í ÀÖ´Ù
      • ÀÇ·á ÀÎÇÁ¶ó ½Ã¼³ÀÇ ¾÷±×·¹À̵带 À§ÇÑ Á¤ºÎ º¸Á¶±Ý°ú ´ëó
    • ¾ïÁ¦¿äÀÎ
      • ´ëü Ä¡·á¹ýÀÇ ÀÌ¿ë °¡´É¼º
    • ±âȸ
      • ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½Ã½ºÅÛÀÇ Á¦Ç° °³¹ß°ú »õ·Î¿î Áøº¸
      • EVH ½Ã½ºÅÛÀÇ ÀÏȸ¿ë ºÎ¹®ÀÇ º¸±Þ
    • °úÁ¦
      • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • ¼Ò°³
  • ºÎ¼Óǰ
  • ³»½Ã°æ
  • EVH ½Ã½ºÅÛ

Á¦7Àå ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå : »ç¿ë¼ºº°

  • ¼Ò°³
  • ÀÏȸ¿ë
  • Àç»ç¿ë °¡´É

Á¦8Àå ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå : Ç÷°ü À¯Çüº°

  • ¼Ò°³
  • ¿ä°ñµ¿¸Æ
  • º¹ÀçÁ¤¸Æ

Á¦9Àå ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • °ü»óµ¿¸ÆÁúȯ
  • ¸»Ãʵ¿¸ÆÁúȯ

Á¦10Àå ¾Æ¸Þ¸®Ä« ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³»½Ã°æ Ç÷°ü äÃë ½Ã½ºÅÛ ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Fujifilm Holdings Corporation
  • Getinge AB
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • LivaNova, Inc.
  • Machida Endoscope Co., Ltd
  • Med Europe Srl
  • Medtronic PLC
  • Olympus Corporation
  • PENTAX Medical
  • Richard Wolf GmbH
  • Smith & Nephew PLC
  • STERIS
  • Stryker Corporation
JHS 24.11.21

The Endoscopic Vessel Harvesting Market was valued at USD 2.06 billion in 2023, expected to reach USD 2.25 billion in 2024, and is projected to grow at a CAGR of 9.70%, to USD 3.94 billion by 2030.

Endoscopic Vessel Harvesting (EVH) is a minimally invasive procedure used in cardiac surgeries to obtain blood vessels, predominantly the saphenous vein, necessary for coronary artery bypass grafting (CABG). The contemporary scope of EVH highlights its significance in reducing surgical trauma, decreasing wound complications, and enhancing patient recovery times, thereby necessitating its implementation in cardiac care units globally. The primary application of endoscopic vessel harvesting lies in improving surgical outcomes for cardiac patients, catering predominantly to hospitals and specialized cardiac centers for CABG procedures. The market is positively influenced by the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive procedures, and advancements in endoscopic technologies. As healthcare systems worldwide emphasize cost-effective and patient-friendly procedures, the EVH market finds growing opportunities, particularly in emerging markets with developing healthcare infrastructures. Leading advancements in instrumentation and imaging, along with integration of AI and robotics, represent potential areas for innovation and market leadership, offering insights into business growth opportunities. However, the market faces challenges such as high costs of EVH devices, stringent regulatory compliances, and a lack of skilled professionals proficient in using advanced endoscopic technologies. Additionally, limited awareness among healthcare providers in less developed regions can restrict market penetration. To capitalize on current opportunities, businesses should focus on expanding training programs to upskill healthcare professionals in the use of EVH techniques, and invest in R&D to engineer cost-effective solutions that can be widely adopted in all healthcare settings. The nature of the EVH market is competitive and rapidly evolving, with a strong emphasis on technological innovation and strategic partnerships to capture a substantial market share while navigating potential obstacles.

KEY MARKET STATISTICS
Base Year [2023] USD 2.06 billion
Estimated Year [2024] USD 2.25 billion
Forecast Year [2030] USD 3.94 billion
CAGR (%) 9.70%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endoscopic Vessel Harvesting Market

The Endoscopic Vessel Harvesting Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising cases of cardiovascular diseases globally
    • Increasing preference for minimally invasive harvesting procedures
    • Government grants and initiatives to upgrade healthcare infrastructure facilities
  • Market Restraints
    • Availability of alternative treatment methods
  • Market Opportunities
    • Product development and new advancements in endoscopic vessel harvesting systems
    • Proliferation of single-use segment of the EVH systems
  • Market Challenges
    • Lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Endoscopic Vessel Harvesting Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endoscopic Vessel Harvesting Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endoscopic Vessel Harvesting Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endoscopic Vessel Harvesting Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endoscopic Vessel Harvesting Market

A detailed market share analysis in the Endoscopic Vessel Harvesting Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endoscopic Vessel Harvesting Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endoscopic Vessel Harvesting Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endoscopic Vessel Harvesting Market

A strategic analysis of the Endoscopic Vessel Harvesting Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endoscopic Vessel Harvesting Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Getinge AB, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, LivaNova, Inc., Machida Endoscope Co., Ltd, Med Europe S.r.l., Medtronic PLC, Olympus Corporation, PENTAX Medical, Richard Wolf GmbH, Smith & Nephew PLC, STERIS, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Endoscopic Vessel Harvesting Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Endoscopes, and EVH Systems.
  • Based on Usability, market is studied across Disposable and Reusable.
  • Based on Vessel Type, market is studied across Radial Artery and Saphenous Vein.
  • Based on Application, market is studied across Coronary Artery Disease and Peripheral Artery Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising cases of cardiovascular diseases globally
      • 5.1.1.2. Increasing preference for minimally invasive harvesting procedures
      • 5.1.1.3. Government grants and initiatives to upgrade healthcare infrastructure facilities
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative treatment methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Product development and new advancements in endoscopic vessel harvesting systems
      • 5.1.3.2. Proliferation of single-use segment of the EVH systems
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Endoscopic Vessel Harvesting Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Endoscopes
  • 6.4. EVH Systems

7. Endoscopic Vessel Harvesting Market, by Usability

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Endoscopic Vessel Harvesting Market, by Vessel Type

  • 8.1. Introduction
  • 8.2. Radial Artery
  • 8.3. Saphenous Vein

9. Endoscopic Vessel Harvesting Market, by Application

  • 9.1. Introduction
  • 9.2. Coronary Artery Disease
  • 9.3. Peripheral Artery Disease

10. Americas Endoscopic Vessel Harvesting Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Endoscopic Vessel Harvesting Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Endoscopic Vessel Harvesting Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Becton, Dickinson and Company
  • 3. Boston Scientific Corporation
  • 4. CONMED Corporation
  • 5. Cook Group Incorporated
  • 6. Fujifilm Holdings Corporation
  • 7. Getinge AB
  • 8. Johnson & Johnson Services, Inc.
  • 9. KARL STORZ SE & Co. KG
  • 10. LivaNova, Inc.
  • 11. Machida Endoscope Co., Ltd
  • 12. Med Europe S.r.l.
  • 13. Medtronic PLC
  • 14. Olympus Corporation
  • 15. PENTAX Medical
  • 16. Richard Wolf GmbH
  • 17. Smith & Nephew PLC
  • 18. STERIS
  • 19. Stryker Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦